- Home
- EXEL vs CNA Comparison
EXEL vs CNA Comparison
Compare EXEL & CNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EXEL | CNA |
|---|---|---|
| Founded | 1994 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.9B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | CNA |
|---|---|---|
| Price | $44.47 | $46.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 23 | 1 |
| Target Price | $45.45 | ★ $53.00 |
| AVG Volume (30 Days) | ★ 2.2M | 326.6K |
| Earning Date | 02-10-2026 | 02-09-2026 |
| Dividend Yield | N/A | ★ 8.30% |
| EPS Growth | ★ 53.55 | N/A |
| EPS | 2.38 | ★ 3.66 |
| Revenue | $2,288,218,000.00 | ★ $14,850,000,000.00 |
| Revenue This Year | $9.74 | N/A |
| Revenue Next Year | $12.27 | $21.34 |
| P/E Ratio | $18.63 | ★ $12.65 |
| Revenue Growth | ★ 9.93 | 5.41 |
| 52 Week Low | $31.90 | $43.29 |
| 52 Week High | $49.62 | $51.34 |
Technical Indicators
Market Signals| Indicator | EXEL | CNA |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 45.53 |
| Support Level | $43.00 | $45.81 |
| Resistance Level | $45.41 | $46.93 |
| Average True Range (ATR) | 1.65 | 0.78 |
| MACD | -0.09 | -0.09 |
| Stochastic Oscillator | 58.22 | 39.20 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About CNA CNA Financial Corporation
CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.